FDA Launches Rare Disease Framework Initiative
November 13, 2026
November 13, 2026
DANVERS, Massachusetts, Nov. 13 -- The National Scleroderma Foundation posted the following news:
* * *
FDA Launches Rare Disease Framework Initiative
*
On October 14, the U.S. Food and Drug Administration (FDA) launched its Rare Disease Framework Initiative to rethink how drugs and biologics are developed for rare diseases through what the agency describes as a "fit-for-purpose" approach. Read the FDA announcement.
In de . . .
* * *
FDA Launches Rare Disease Framework Initiative
*
On October 14, the U.S. Food and Drug Administration (FDA) launched its Rare Disease Framework Initiative to rethink how drugs and biologics are developed for rare diseases through what the agency describes as a "fit-for-purpose" approach. Read the FDA announcement.
In de . . .